Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,690,355
-
Total 13F shares
-
164,989,974
-
Share change
-
+1,595,575
-
Total reported value
-
$1,887,503,875
-
Put/Call ratio
-
56%
-
Price per share
-
$11.44
-
Number of holders
-
248
-
Value change
-
+$27,460,717
-
Number of buys
-
107
-
Number of sells
-
121
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) as of Q4 2023
As of 31 Dec 2023,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) was held by
248 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
164,989,974 shares.
The largest 10 holders included
BlackRock Inc., Sarissa Capital Management LP, VANGUARD GROUP INC, STATE STREET CORP, LSV ASSET MANAGEMENT, RENAISSANCE TECHNOLOGIES LLC, ARMISTICE CAPITAL, LLC, CREDIT SUISSE AG/, VICTORY CAPITAL MANAGEMENT INC, and BROWN CAPITAL MANAGEMENT LLC.
This page lists
248
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.